News

Filter

Current filters:

TarcevaPfizer

1 to 9 of 27 results

Mylan enters Tarceva settlement agreement

24-07-2013

US generics firm Mylan (Nasdaq: MYL) has entered into a settlement agreement with OSI Pharmaceuticals,…

GenentechGenericsLegalMylan LaboratoriesNorth AmericaOncologyOSI PharmaceuticalsPatentsPfizerTarceva

75% of US oncologists prescribe Pfizer's Xalkori just 10 months after the drug's launch

21-06-2012

US oncologists surveyed by advisory firm Decision Resources say they prescribe drugs behemoth Pfizer's…

GlaxoSmithKlineHerceptinMarkets & MarketingNorth AmericaOncologyPfizerPharmaceuticalResearchRocheTarcevaTykerbXalkori

Stock Commentary - New York week to May 18, 2009

21-05-2009

NEW YORK: saw another volatile week in the reporting period to May 18, with the last trading day witnessing…

erlotinibGenentechPfizerTarcevaWyeth

1 to 9 of 27 results

Back to top